enovis surgical gb limited
enovis surgical gb limited Company Information
Company Number
07112154
Next Accounts
Sep 2025
Shareholders
limacorporate spa
Group Structure
View All
Industry
General medical practice activities
Registered Address
4 office village forder way, cygnet park hampton, peterborough, peterborough, PE7 8GX
Website
www.limacorporate.comenovis surgical gb limited Estimated Valuation
Pomanda estimates the enterprise value of ENOVIS SURGICAL GB LIMITED at £14.2m based on a Turnover of £19.6m and 0.72x industry multiple (adjusted for size and gross margin).
enovis surgical gb limited Estimated Valuation
Pomanda estimates the enterprise value of ENOVIS SURGICAL GB LIMITED at £12.9m based on an EBITDA of £2.4m and a 5.38x industry multiple (adjusted for size and gross margin).
enovis surgical gb limited Estimated Valuation
Pomanda estimates the enterprise value of ENOVIS SURGICAL GB LIMITED at £19.5m based on Net Assets of £7.7m and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Enovis Surgical Gb Limited Overview
Enovis Surgical Gb Limited is a live company located in peterborough, PE7 8GX with a Companies House number of 07112154. It operates in the general medical practice activities sector, SIC Code 86210. Founded in December 2009, it's largest shareholder is limacorporate spa with a 100% stake. Enovis Surgical Gb Limited is a established, mid sized company, Pomanda has estimated its turnover at £19.6m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Enovis Surgical Gb Limited Health Check
Pomanda's financial health check has awarded Enovis Surgical Gb Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
7 Weak
Size
annual sales of £19.6m, make it larger than the average company (£1.7m)
£19.6m - Enovis Surgical Gb Limited
£1.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 28%, show it is growing at a faster rate (8.5%)
28% - Enovis Surgical Gb Limited
8.5% - Industry AVG
Production
with a gross margin of 32.3%, this company has a higher cost of product (46.8%)
32.3% - Enovis Surgical Gb Limited
46.8% - Industry AVG
Profitability
an operating margin of 5.7% make it as profitable than the average company (5.2%)
5.7% - Enovis Surgical Gb Limited
5.2% - Industry AVG
Employees
with 49 employees, this is above the industry average (16)
49 - Enovis Surgical Gb Limited
16 - Industry AVG
Pay Structure
on an average salary of £74.3k, the company has a higher pay structure (£38.8k)
£74.3k - Enovis Surgical Gb Limited
£38.8k - Industry AVG
Efficiency
resulting in sales per employee of £401k, this is more efficient (£93.4k)
£401k - Enovis Surgical Gb Limited
£93.4k - Industry AVG
Debtor Days
it gets paid by customers after 74 days, this is later than average (39 days)
74 days - Enovis Surgical Gb Limited
39 days - Industry AVG
Creditor Days
its suppliers are paid after 4 days, this is quicker than average (25 days)
4 days - Enovis Surgical Gb Limited
25 days - Industry AVG
Stock Days
it holds stock equivalent to 227 days, this is more than average (20 days)
227 days - Enovis Surgical Gb Limited
20 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 8 weeks, this is less cash available to meet short term requirements (43 weeks)
8 weeks - Enovis Surgical Gb Limited
43 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 57.8%, this is a higher level of debt than the average (49.5%)
57.8% - Enovis Surgical Gb Limited
49.5% - Industry AVG
ENOVIS SURGICAL GB LIMITED financials
Enovis Surgical Gb Limited's latest turnover from December 2023 is £19.6 million and the company has net assets of £7.7 million. According to their latest financial statements, Enovis Surgical Gb Limited has 49 employees and maintains cash reserves of £1.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 19,648,650 | 14,990,887 | 11,644,673 | 9,359,883 | 13,969,217 | 13,839,737 | 13,879,474 | 11,934,159 | ||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | 13,307,655 | 8,798,217 | 6,695,401 | 4,821,705 | 8,823,229 | 8,180,267 | 7,803,098 | 6,054,517 | ||||||
| Gross Profit | 6,340,995 | 6,192,670 | 4,949,272 | 4,538,178 | 5,145,988 | 5,659,470 | 6,076,376 | 5,879,642 | ||||||
| Admin Expenses | 5,214,446 | 4,779,369 | 4,495,954 | 4,136,599 | 4,805,818 | 4,662,981 | 4,543,989 | 4,805,308 | ||||||
| Operating Profit | 1,126,549 | 1,413,301 | 453,318 | 401,579 | 340,170 | 996,489 | 1,532,387 | 1,074,334 | ||||||
| Interest Payable | 144,643 | 144,678 | 144,643 | 144,643 | 144,643 | 144,643 | 151,783 | 145,103 | ||||||
| Interest Receivable | 703 | 121 | 1,217 | 2,805 | 504 | 479 | 821 | 290 | ||||||
| Pre-Tax Profit | 982,609 | 1,268,744 | 309,892 | 259,741 | 196,031 | 852,325 | 1,381,425 | 929,521 | ||||||
| Tax | -167,388 | -321,325 | -58,549 | -49,849 | -37,158 | -160,914 | -268,075 | -190,320 | ||||||
| Profit After Tax | 815,221 | 947,419 | 251,343 | 209,892 | 158,873 | 691,411 | 1,113,350 | 739,201 | ||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | 815,221 | 947,419 | 251,343 | 209,892 | 158,873 | 691,411 | 1,113,350 | 739,201 | ||||||
| Employee Costs | 3,638,915 | 3,110,834 | 2,774,405 | 2,615,127 | 3,156,265 | 2,590,671 | 2,454,305 | 2,420,429 | ||||||
| Number Of Employees | 49 | 40 | 40 | 42 | 42 | 39 | 35 | 31 | 23 | |||||
| EBITDA* | 2,404,713 | 2,632,282 | 1,660,821 | 1,753,687 | 1,659,005 | 2,246,376 | 2,669,165 | 1,970,362 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,553,774 | 2,261,108 | 2,044,208 | 2,432,438 | 2,497,826 | 2,081,335 | 2,352,288 | 2,399,384 | 1,657,495 | 931,786 | 622,029 | 855,744 | 1,038,915 | 664,304 |
| Intangible Assets | 1,541,973 | 1,687,419 | 1,832,865 | 1,978,311 | 2,123,757 | 2,269,203 | 2,414,648 | 2,560,094 | 2,705,539 | 2,850,985 | ||||
| Investments & Other | ||||||||||||||
| Debtors (Due After 1 year) | ||||||||||||||
| Total Fixed Assets | 4,095,747 | 3,948,527 | 3,877,073 | 4,410,749 | 4,621,583 | 4,350,538 | 4,766,936 | 4,959,478 | 4,363,034 | 3,782,771 | 622,029 | 855,744 | 1,038,915 | 664,304 |
| Stock & work in progress | 8,312,546 | 7,747,899 | 7,560,380 | 8,362,397 | 7,585,083 | 6,888,076 | 5,848,838 | 5,884,851 | 4,624,188 | 3,133,758 | 2,736,255 | 2,827,123 | 2,668,677 | 1,650,772 |
| Trade Debtors | 4,005,562 | 2,564,282 | 1,629,231 | 1,508,171 | 2,203,497 | 2,178,052 | 2,408,463 | 2,893,728 | 2,962,487 | 1,572,057 | 1,261,593 | 642,339 | 491,655 | 520,952 |
| Group Debtors | ||||||||||||||
| Misc Debtors | 210,001 | 109,573 | 128,956 | 389,687 | 329,255 | 96,112 | 74,920 | 108,553 | 44,241 | |||||
| Cash | 1,721,514 | 908,473 | 963,127 | 1,248,740 | 1,567,503 | 753,691 | 1,030,800 | 884,279 | 506,042 | 849,362 | 262,983 | 452,882 | 282,822 | 662,239 |
| misc current assets | 203 | 6,763 | 1,853 | 2,750 | 1,941 | 1,067 | ||||||||
| total current assets | 14,249,623 | 11,330,227 | 10,281,694 | 11,508,995 | 11,685,338 | 9,915,931 | 9,363,021 | 9,771,614 | 8,136,958 | 5,561,940 | 4,262,684 | 3,925,094 | 3,445,095 | 2,835,030 |
| total assets | 18,345,370 | 15,278,754 | 14,158,767 | 15,919,744 | 16,306,921 | 14,266,469 | 14,129,957 | 14,731,092 | 12,499,992 | 9,344,711 | 4,884,713 | 4,780,838 | 4,484,010 | 3,499,334 |
| Bank overdraft | ||||||||||||||
| Bank loan | ||||||||||||||
| Trade Creditors | 180,324 | 154,827 | 73,791 | 147,786 | 118,146 | 93,144 | 129,378 | 406,454 | 239,367 | 7,977,373 | 4,225,471 | 4,233,327 | 4,159,527 | 3,244,230 |
| Group/Directors Accounts | 8,543,691 | 6,717,119 | 6,662,086 | 8,877,282 | 9,167,102 | 7,636,589 | 8,214,548 | 9,554,620 | 8,482,372 | |||||
| other short term finances | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| other current liabilities | 1,452,170 | 1,139,032 | 1,289,717 | 1,071,466 | 1,456,595 | 1,172,583 | 1,047,921 | 1,090,670 | 858,062 | |||||
| total current liabilities | 10,176,185 | 8,010,978 | 8,025,594 | 10,096,534 | 10,741,843 | 8,902,316 | 9,391,847 | 11,051,744 | 9,579,801 | 7,977,373 | 4,225,471 | 4,233,327 | 4,159,527 | 3,244,230 |
| loans | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | ||||||||||||||
| provisions | 422,284 | 336,096 | 148,912 | 90,292 | 42,052 | 65,368 | 119,956 | 100,000 | 40,820 | 1,036 | 2,182 | 48,809 | 47,548 | |
| total long term liabilities | 422,284 | 336,096 | 148,912 | 90,292 | 42,052 | 65,368 | 119,956 | 100,000 | 40,820 | 1,036 | 2,182 | 48,809 | 47,548 | |
| total liabilities | 10,598,469 | 8,347,074 | 8,174,506 | 10,186,826 | 10,783,895 | 8,902,316 | 9,457,215 | 11,171,700 | 9,679,801 | 8,018,193 | 4,226,507 | 4,235,509 | 4,208,336 | 3,291,778 |
| net assets | 7,746,901 | 6,931,680 | 5,984,261 | 5,732,918 | 5,523,026 | 5,364,153 | 4,672,742 | 3,559,392 | 2,820,191 | 1,326,518 | 658,206 | 545,329 | 275,674 | 207,556 |
| total shareholders funds | 7,746,901 | 6,931,680 | 5,984,261 | 5,732,918 | 5,523,026 | 5,364,153 | 4,672,742 | 3,559,392 | 2,820,191 | 1,326,518 | 658,206 | 545,329 | 275,674 | 207,556 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 1,126,549 | 1,413,301 | 453,318 | 401,579 | 340,170 | 996,489 | 1,532,387 | 1,074,334 | ||||||
| Depreciation | 1,132,718 | 1,073,535 | 1,062,057 | 1,206,662 | 1,173,389 | 1,104,442 | 991,332 | 750,583 | 496,766 | 407,498 | 393,838 | 389,658 | 300,311 | 100,394 |
| Amortisation | 145,446 | 145,446 | 145,446 | 145,446 | 145,446 | 145,445 | 145,446 | 145,445 | 145,446 | 57,931 | ||||
| Tax | -167,388 | -321,325 | -58,549 | -49,849 | -37,158 | -160,914 | -268,075 | -190,320 | ||||||
| Stock | 564,647 | 187,519 | -802,017 | 777,314 | 697,007 | 1,039,238 | -36,013 | 1,260,663 | 1,490,430 | 397,503 | -90,868 | 158,446 | 1,017,905 | 1,650,772 |
| Debtors | 1,541,708 | 915,668 | -139,671 | -634,894 | 258,588 | -209,219 | -518,898 | -4,447 | 1,434,671 | 310,464 | 619,254 | 150,684 | -29,297 | 520,952 |
| Creditors | 25,497 | 81,036 | -73,995 | 29,640 | 25,002 | -36,234 | -277,076 | 167,087 | -7,738,006 | 3,751,902 | -7,856 | 73,800 | 915,297 | 3,244,230 |
| Accruals and Deferred Income | 313,138 | -150,685 | 218,251 | -385,129 | 284,012 | 124,662 | -42,749 | 232,608 | 858,062 | |||||
| Deferred Taxes & Provisions | 86,188 | 187,184 | 58,620 | 48,240 | 42,052 | -65,368 | -54,588 | 19,956 | 59,180 | 39,784 | -1,146 | -46,627 | 1,261 | 47,548 |
| Cash flow from operations | 555,793 | 1,325,305 | 2,746,836 | 1,254,169 | 1,017,318 | 1,278,503 | 2,581,588 | 943,477 | ||||||
| Investing Activities | ||||||||||||||
| capital expenditure | -768,285 | -883,263 | -1,236,950 | |||||||||||
| Change in Investments | ||||||||||||||
| cash flow from investments | -768,285 | -883,263 | -1,236,950 | |||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | ||||||||||||||
| Group/Directors Accounts | 1,826,572 | 55,033 | -2,215,196 | -289,820 | 1,530,513 | -577,959 | -1,340,072 | 1,072,248 | 8,482,372 | |||||
| Other Short Term Loans | ||||||||||||||
| Long term loans | ||||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||||
| other long term liabilities | ||||||||||||||
| share issue | ||||||||||||||
| interest | -143,940 | -144,557 | -143,426 | -141,838 | -144,139 | -144,164 | -150,962 | -144,813 | ||||||
| cash flow from financing | 1,682,632 | -89,524 | -2,358,622 | -431,658 | 1,386,374 | -722,123 | -1,491,034 | 927,435 | ||||||
| cash and cash equivalents | ||||||||||||||
| cash | 813,041 | -54,654 | -285,613 | -318,763 | 813,812 | -277,109 | 146,521 | 378,237 | -343,320 | 586,379 | -189,899 | 170,060 | -379,417 | 662,239 |
| overdraft | ||||||||||||||
| change in cash | 813,041 | -54,654 | -285,613 | -318,763 | 813,812 | -277,109 | 146,521 | 378,237 | -343,320 | 586,379 | -189,899 | 170,060 | -379,417 | 662,239 |
enovis surgical gb limited Credit Report and Business Information
Enovis Surgical Gb Limited Competitor Analysis
Perform a competitor analysis for enovis surgical gb limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in PE7 area or any other competitors across 12 key performance metrics.
enovis surgical gb limited Ownership
ENOVIS SURGICAL GB LIMITED group structure
Enovis Surgical Gb Limited has no subsidiary companies.
Ultimate parent company
EQT FUND VII
#0114355
LIMACORPORATE SPA
#0082316
2 parents
ENOVIS SURGICAL GB LIMITED
07112154
enovis surgical gb limited directors
Enovis Surgical Gb Limited currently has 2 directors. The longest serving directors include Michele Marin (Apr 2022) and Mr Daniel Pryor (Jan 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Michele Marin | United Kingdom | 55 years | Apr 2022 | - | Director |
| Mr Daniel Pryor | England | 57 years | Jan 2024 | - | Director |
P&L
December 2023turnover
19.6m
+31%
operating profit
1.1m
-20%
gross margin
32.3%
-21.88%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
7.7m
+0.12%
total assets
18.3m
+0.2%
cash
1.7m
+0.89%
net assets
Total assets minus all liabilities
enovis surgical gb limited company details
company number
07112154
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
December 2009
age
16
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
lima orthopaedics uk limited (October 2024)
accountant
-
auditor
TC GROUP
address
4 office village forder way, cygnet park hampton, peterborough, peterborough, PE7 8GX
Bank
-
Legal Advisor
-
enovis surgical gb limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to enovis surgical gb limited. Currently there are 0 open charges and 3 have been satisfied in the past.
enovis surgical gb limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ENOVIS SURGICAL GB LIMITED. This can take several minutes, an email will notify you when this has completed.
enovis surgical gb limited Companies House Filings - See Documents
| date | description | view/download |
|---|
